Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Journal of Thyroid Research
|
December 24, 2015
Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
Ateesha F Mohamed, Juan Marcos González, Angelyn Fairchild
The Patient
|
April 25, 2024
An Overview of Data Collection in Health Preference Research
Semra Ozdemir, Matthew Quaife, Ateesha F Mohamed, et al.
Pharmacoeconomics
|
August 23, 2011
Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma
Ateesha F Mohamed, A Brett Hauber, Maureen P Neary
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 16, 2014
Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening
Vikram Kilambi, F Reed Johnson, Juan Marcos González, et al.
Health Economics
|
March 10, 2009
Who pays attention in stated-choice surveys?
Semra Ozdemir, Ateesha F Mohamed, F Reed Johnson, et al.
The Patient
|
January 26, 2012
Patient preferences and linear scoring rules for patient-reported outcomes
Ateesha F Mohamed, A Brett Hauber, F Reed Johnson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2008
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings
David S Ettinger, Steven M Grunberg, A Brett Hauber, et al.
The Patient
|
July 11, 2012
Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection
Teresa L Kauf, Ateesha F Mohamed, A Brett Hauber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2014
Meta-analysis for the association between overall survival and progression-free survival in gastrointestinal stromal tumor
Ipek Özer-Stillman, Lauren Strand, Jane Chang, et al.
Health Economics
|
March 11, 2010
How does cost matter in health-care discrete-choice experiments?
F Reed Johnson, Ateesha F Mohamed, Semra Ozdemir, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Journal of Thyroid Research
|
December 24, 2015
Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
Ateesha F Mohamed, Juan Marcos González, Angelyn Fairchild
The Patient
|
April 25, 2024
An Overview of Data Collection in Health Preference Research
Semra Ozdemir, Matthew Quaife, Ateesha F Mohamed, et al.
Pharmacoeconomics
|
August 23, 2011
Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma
Ateesha F Mohamed, A Brett Hauber, Maureen P Neary
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 16, 2014
Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening
Vikram Kilambi, F Reed Johnson, Juan Marcos González, et al.
Health Economics
|
March 10, 2009
Who pays attention in stated-choice surveys?
Semra Ozdemir, Ateesha F Mohamed, F Reed Johnson, et al.
The Patient
|
January 26, 2012
Patient preferences and linear scoring rules for patient-reported outcomes
Ateesha F Mohamed, A Brett Hauber, F Reed Johnson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2008
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings
David S Ettinger, Steven M Grunberg, A Brett Hauber, et al.
The Patient
|
July 11, 2012
Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection
Teresa L Kauf, Ateesha F Mohamed, A Brett Hauber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2014
Meta-analysis for the association between overall survival and progression-free survival in gastrointestinal stromal tumor
Ipek Özer-Stillman, Lauren Strand, Jane Chang, et al.
Health Economics
|
March 11, 2010
How does cost matter in health-care discrete-choice experiments?
F Reed Johnson, Ateesha F Mohamed, Semra Ozdemir, et al.
Page
of 5